Detalhe da pesquisa
1.
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis.
Gastroenterology
; 160(1): 115-127.e30, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32763240
2.
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
Clin Infect Dis
; 72(12): 2132-2140, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32255488
3.
Agrobacterium tumefaciens exoR controls acid response genes and impacts exopolysaccharide synthesis, horizontal gene transfer, and virulence gene expression.
J Bacteriol
; 196(18): 3221-33, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24982308
4.
Agrobacterium tumefaciens ExoR represses succinoglycan biosynthesis and is required for biofilm formation and motility.
Microbiology (Reading)
; 156(Pt 9): 2670-2681, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20576688
5.
Mechanisms and regulation of polar surface attachment in Agrobacterium tumefaciens.
Curr Opin Microbiol
; 12(6): 708-14, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19879182
6.
Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway.
J Immunol
; 169(6): 2846-50, 2002 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12218096